Journal Article (Letter)

DKFZ-2025-02131

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Impaired glucose metabolism in irritable bowel syndrome: personalised low-glycaemic diet as potential therapeutic target.

Schmelter, F. ; Schröder, T. ; Laumonnier, Y. ; consortium, O.-C. (Collaboration Author) ; Bischoff, S. C. ; Derer, S. ; Jensen, B. A. H. ; Sina, C. ; Katalinic, A. (Contributor) ; Oberländer, M. (Contributor) ; Deck, R. (Contributor) ; Derer, S. (Contributor) ; Sültmann, H. (Contributor)DKFZ* ; Bubnoff, N. v. (Contributor) ; Gemoll, T. (Contributor) ; Busch, H. (Contributor) ; Jülg, P. (Contributor) ; Hutzenlaub, T. (Contributor) ; Sina, C. (Contributor) ; Schröder, T. (Contributor) ; Burziwoda, D. (Contributor)

2026
BMJ Publishing Group London

This record in other databases:  

Please use a persistent id in citations: doi:10.1136/gutjnl-2025-336797

Keyword(s): BIOMARKERS ; GLUCOSE METABOLISM ; IRRITABLE BOWEL SYNDROME ; NUTRITION

---

Contributing Institute(s):

1. B063 Krebsgenomforschung (B063)

Research Program(s):

1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2025

---

Database coverage:
; ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; National-Konsortium ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---